Robert Kramer, PhD is an advisor to several biotech companies. He is an accomplished pharmaceutical executive who led successful oncology research teams as vice president, oncology, and immunology drug discovery at Bristol Myers Squibb; and as vice president, global head oncology drug discovery at Janssen Pharmaceuticals. In those roles, he provided direct management oversight for more than 40 development candidates that advanced into clinical development, resulting in several approved cancer drugs.
Robert earned his PhD in pharmacology from the University of Vermont. Early in his career, he served as an assistant professor at Harvard Medical School.